TipRanks
Go Ultimate55% OFF

Compare Shanghai Pharmaceuticals Holding Co (SHPMF) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
SHPMFShanghai Pharmaceuticals Holding Co$1.41$8.22B12.05-9.06%Moderate BuyUnlock the SHPMF analyst price target with TipRanks PremiumSHPMFUnlock the SHPMF top-analyst price target with TipRanks Premium
HK:0673China Health GroupHKD 0.26HKD 360.66M-5.29-50.00%―Unlock the HK:0673 analyst price target with TipRanks PremiumSHPMF vs HK:0673Unlock the HK:0673 top-analyst price target with TipRanks Premium
HK:1099Sinopharm Group CoHKD 16.34HKD 50.52B6.16-15.64%Strong BuyUnlock the HK:1099 analyst price target with TipRanks PremiumSHPMF vs HK:1099Unlock the HK:1099 top-analyst price target with TipRanks Premium
HK:1931IVD Medical Holding LimitedHKD 0.36HKD 575.63M-6.47-94.92%―Unlock the HK:1931 analyst price target with TipRanks PremiumSHPMF vs HK:1931Unlock the HK:1931 top-analyst price target with TipRanks Premium
HK:2192Medlive Technology Co., Ltd.HKD 6.29HKD 4.67B11.61-40.38%Moderate BuyUnlock the HK:2192 analyst price target with TipRanks PremiumSHPMF vs HK:2192Unlock the HK:2192 top-analyst price target with TipRanks Premium
HK:2289Charmacy Pharmaceutical Co., Ltd. Class HHKD 5.49HKD 592.92M10.841.10%―Unlock the HK:2289 analyst price target with TipRanks PremiumSHPMF vs HK:2289Unlock the HK:2289 top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
SHPMFShanghai Pharmaceuticals Holding Co1.41-0.14-8.77%
HK:0673China Health Group0.26-0.36-58.06%
HK:1099Sinopharm Group Co16.34-2.02-11.03%
HK:1931IVD Medical Holding Limited0.35-5.93-94.35%
HK:2192Medlive Technology Co., Ltd.6.29-4.04-39.13%
HK:2289Charmacy Pharmaceutical Co., Ltd. Class H5.490.387.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts